Klarman Family Foundation 13D and 13G filings for Foghorn Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-08 5:44 pm Unchanged |
2024-09-30 | 13G | Foghorn Therapeutics Inc. FHTX |
Klarman Family Foundation | 2,139,639 3.900% |
0 (Unchanged) |
Filing |
| 2021-02-03 6:27 pm Purchase |
2020-12-31 | 13G | Foghorn Therapeutics Inc. FHTX |
Klarman Family Foundation | 2,139,639 5.970% |
2,139,639 (New Position) |
Filing |